The Coronavirus pandemic continues to sweep across the globe. It is causing a lot of stress, fear, and uncertainty to people, especially to the care providers, older adults, and those who are already living with underlying health conditions. The global lockdown has greatly affected routines, activities, and livelihoods, leading to a surge in the number … Continue reading Looking after your mental health during COVID-19 pandemic
Diabetes is a global epidemic and the number of people with diabetes globally is growing at an alarming rate. An estimated 463 million adults (20-79 years), or about 1 in 11 adults worldwide, are living with diabetes across the world in 2019; by 2045 this will rise to 700 million1. Globally, the number of people … Continue reading Early Insulinization Can be Key to Effective Diabetes Management
Diabetes Mellitus is a major health issue with nearly half a billion people living with this ailment globally. Diabetes is a serious, chronic or long-term condition that occurs when there are elevated levels of glucose in a person’s blood because their body cannot produce any or enough of the hormone insulin, or cannot effectively use … Continue reading A Disease of Halves: Why better patient adherence to treatment is important to manage diabetes?
Kiran Mazumdar Shaw speaks at the UNAIDS Health Innovation Exchange Meeting on the sidelines of United Nations General Assembly, held in New York on 25th September 2019. Your Excellencies, Distinguished Ladies and Gentlemen, We have just witnessed the first UN High Level meeting on Universal Health Care on Monday. Governments have a collective moral responsibility … Continue reading Kiran Mazumdar-Shaw Promises to Enable Universal Access to rh-Insulin by Reducing Prices to Less than 10 US cents/Day for LMICs
India and the U.S. are witnessing a deepening of ties with a convergence of views on many issues. India is rapidly emerging as a preferred economic and technology partner for the US. India IT and pharma companies have made significant investments and have created jobs in the US. These investments signal a growing economic interdependence … Continue reading US-India Leaders Summit: Paving the Way for Affordable Diabetes & Cancer Care in the US
Biocon recently presented data from its Insulin Tregopil clinical program at the American Diabetes Association’s (ADA) 78th Scientific Sessions held at Orlando, Florida, from 22nd to 26th June, 2018.
Professor Vivekanand Jha shares his views on how Dialysis is one of the first technological innovations in medicine and why we need to leverage this technology to address the huge kidney failure burden our country faces.
CEO Speaks: On the major milestone for Biocon-Sandoz and how this collaboration will enable Biocon to address the next wave of Global Biosimilar Opportunities!
Mr. Suresh Subramanian, Senior Vice President & Head Branded Formulations, Biocon shares his views on how KRABEVA® can make a significant impact in the biosimilars space.
Seema Ahuja, VP & Global Head of Communications, Biocon speaks on Healthcare PR, key challenges faced by the Healthcare and Pharma businesses & how in-house communication teams manage and navigate regulatory issues.